Concepedia

Nabih Maslah

NM

13

Publications

533

Citations

11

H-Index

2018

Active since

Affiliations

Inserm(Current)

Hôpital Saint-Louis

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Délégation Paris 7

Nabih Maslah is an author at Inserm specializing in medicine, hematology, and pathology.

ORCID

Top concepts

Publications per year

2018–2024

13

Publications

13

Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia

Nabih Maslah, Norman Salomao, Louis Drevon et al. · Haematologica · 2019 · 135 citations · Full text

Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features

Anna Guadall, Élodie Lesteven, Gil Letort et al. · Thrombosis and Haemostasis · 2018 · 83 citations

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Emmanuelle Verger, Juliette Soret‐Dulphy, Nabih Maslah et al. · Blood Cancer Journal · 2018 · 51 citations · Full text

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses

Pierre-Édouard Debureaux, Bruno Cassinat, Juliette Soret‐Dulphy et al. · Blood Advances · 2020 · 44 citations · Full text

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms

Clémence Marcault, Lin‐Pierre Zhao, Nabih Maslah et al. · Blood · 2021 · 37 citations · Full text

Rows per page

1–5 of 13